The New Era of Diversity Action Plans: Why Integrating Patient Advocacy into Early Clinical Development Is More Essential Than Ever
Consider this: Black Americans account for about 13% of the US population and 22% of yearly cancer cases, but the median enrollment of Black Americans in clinical trials was about 4.5%,…